DBSA Survey Center Less Common Medication Side Effects Survey

Similar documents
Has a doctor, nurse or other health professional EVER told you that you had tardive dyskinesia caused by a medicine you were using?

Could your uncontrollable movements be tardive dyskinesia (TD)? There s a treatment with INGREZZA.

Doctor Discussion Guide

US Tardive Dyskinesia Market: Size, Trends & Forecasts ( ) December 2016

Could your uncontrollable movements be tardive dyskinesia (TD)?

Lemilvo Tablets (aripiprazole)

DBSA Survey Center Depression Experiences and Treatments Survey

Treatment Options for Bipolar Disorder Contents

FAQ - ARIPIPRAZOLE Educational materials for the Healthcare profesionals

Aripiprazole Accord 5, 10, 15 and 30 mg film-coated tablets

Patient/Caregiver Information Brochure For Bipolar I Disorder in Adolescents

YOUR GUIDE TO ARIPIPRAZOLE Patient/Caregiver Information Brochure

Psychotropic Medication. Including Role of Gradual Dose Reductions

chapter 12 MENTAL HEALTH

Client s Name: Today s Date: Partner s Name (if being seen as a couple): Address, City, State, Zip: Home phone: Work phone: Cell phone:

Data Collection Worksheets

PROVIDED IN RESPONSE TO YOUR UNSOLICITED REQUEST FOR INFORMATION

Report on the data collected by Healthwatch Oldham at our Low Mood, Anxiety and Depression Forum held in January 2017

Understanding. Recognizing the signs of agitation and knowing what to do when they appear. We ve been there. We can help.

Treatment for Bipolar Disorder

PATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE

Mood Disorders Society of Canada Mental Health Care System Study Summary Report

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medications for Early/Mid Stage HD

Evaluation of Grief Support Services Survey. Elective Modules and Questions

Consumer Perception Survey (Formerly Known as POQI)

A-Z of Mental Health Problems

Reading: Andreasen & Black, Introductory Textbook of Psychiatry, 3rd edition, Chapter 21, pp

12/17/2012. Unnecessary Drugs

REGLAN IS A DANGEROUS PSYCHIATRIC DRUG: THE FACTS YOU NEED TO KNOW

Hospital he hospital is located near the interchange of highway 217 and (US 26).

Agenda TOWARDS HOPE AND HEALING: A MENTAL HEALTH AWARENESS EVENT 11/3/2018. Mental Health First Aid. Intro to Mental Health First Aid

Part I. Demographics. Part II. Presenting Problem. Who referred you to WellStar Psychological Services?

The PD You Don t See: Cognitive and Non-motor Symptoms

Part 1 (Twitter, Baby)

Elements for a Public Summary

Abusing drugs can reduce the effectiveness of your treatment, prolong your illness and increase the risk of side effects.

EDC/AFSP Public Perception of Suicide Prevention Survey Results

Descriptions and Characteristics

Beacon Assessment Center

For carers and relatives of people with frontotemporal dementia and semantic dementia. Newsletter

CASE 5 - Toy & Klamen CASE FILES: Psychiatry

Understanding Parkinson s Disease Important information for you and your loved ones

SAMPLE PATIENT SURVEY QUESTIONNAIRE

THE EMERGE SURVEY ON TAKING PART IN BIOBANK RESEARCH: VERSION A

CBT Intake Form. Patient Name: Preferred Name: Last. First. Best contact phone number: address: Address:

Wellness along the Cancer Journey: Palliative Care Revised October 2015

Abnormal Involuntary Movement Scale (AIMS)

Mellaril (thioridazine)

Client Name: Date of Birth: Address: City: Zip code: Hm #: ( ) -. Cell#: ( ) -. Wrk#: ( ) -. Otr#: ( ) -.

Elements for a Public Summary. VI.2.1 Overview of disease epidemiology

Impact of Florida s Medicaid Reform on Recipients of Mental Health Services

MEDICATION GUIDE. Aripiprazole Tablets (AR-i-PIP-ra-zole)

Health Point: Mood Disorders

Survey for Concerned Family and Friends

What Team Members Other Than Prescribers Need To Know About Antipsychotics

Clinical Trial Synopsis TL , NCT#

What s the Diagnosis? A Developmental Perspective

Food Labeling Survey ~ January 2019

Active listening. drugs used to control anxiety and agitation. Antianxiety drugs

OLANZAPINE-SYNTHON Olanzapine benzoate

CITY OF HOPE NATIONAL MEDICAL CENTER QUALITY OF LIFE QUESTIONNAIRE FOR PATIENTS WITH AN OSTOMY

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D.

Not an actual patient

Extrapyramidal Symptoms Associated with Antipsychotic Use

PATIENT REGISTRATION

Typical or Troubled? Teen Mental Health

PRINCIPLES OF CAREGIVING DEVELOPMENTAL DISABILITIES MODULE

Olanzapine generichealth tablets Olanzapine benzoate

Schodack Internal Medicine and Pediatrics. Annual Physical-Female

Behavioural and Psychological Symptoms and Medications Presentation

This initial discovery led to the creation of two classes of first generation antidepressants:

Abilify (aripiprazole)

TETRAZIN (tetrabenazine) Tablets MEDICATION GUIDE. What is the most important information I should know about TETRAZIN?

Summary of the risk management plan (RMP) for Aripiprazole Mylan Pharma (aripiprazole)

Latuda (lurasidone) Summary of the Risk Management Plan (RMP) for the Public

Screening for Depression and Suicide

DEPRESSION AND ANXIETY STATUS IN KANSAS

Non-epileptic attacks

Mood, Emotions and MS

Alcorn & Allison. clinical associates **C O N F I D E N T I A L**

Helping a friend or loved one manage bipolar depression.

PART III: CONSUMER INFORMATION SAPHRIS (asenapine sublingual tablets)

Medication Information for Parents and Teachers

Case Studies: Improving mental health pathways for people from refugee and asylum seeker backgrounds

Client Intake History

Choosing Wisely Psychiatry s Top Priorities for Appropriate Primary Care

Helping Children Cope After A Disaster

Next, I m going to ask you to read several statements. After you read each statement, circle the number that best represents how you feel.

Reading the Signs. Risk Factors and Warning Signs for Suicide

Joseph S. Weiner, MD, PC Patient History Form

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS

AP PSYCH Unit 13.3 Biomedical Therapies

The treatment of bipolar disorder in adults, children and adolescents

Transcription:

Summary Report: March, 2017 BACKGROUND From 10/19/16-11/21/16, DBSA administered a survey to gather information on the experiences people living with mood disorders have had with a variety of medication side effects. This survey focused on the level of distress nine identified side effects has caused the individual as well as who first noticed the side effect and how it has been treated, if at all. Three of these less common side effects indicate a little known condition called tardive dyskinesia (TD). This condition affects the nervous system and is often caused by long-term use of antipsychotic medications, which are sometimes used to treat bipolar disorder and depression. Side effects associated with TD usually involve repetitive, involuntary movements. While most side-effects will dissipate once medication is stopped, TD can last long after the medication has been discontinued and, in some cases, may even be permanent. Because of its unique characteristics and its impact on people living with mood disorders, DBSA placed a special focus on respondents who identified as having tardive dyskinesia. Individuals were invited to complete the survey through DBSA s electronic newsletters distributed to individual constituents and local chapters as well as through social media and Facebook Ads. 2,007 individuals responded. SURVEY RESULTS DIAGNOSIS The majority of respondents reported having multiple diagnoses, with nearly 70% experiencing bipolar disorder, 60% depression, 60% anxiety, 7% substance use disorder, and 4% schizophrenia. With which of the following have you been diagnosed? (Check all that apply.) (All Respondents: n=2,007) substance use disorder 6.93% schizophrenia 4.04% anxiety 59.19% depression 60.14% bipolar disorder 69.01% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% 70.00% 80.00% Page 1 of 7

Among those diagnosed with Tardive Dyskinesia (n=49), there was a much higher percentage of people experiencing bipolar disorder (89.8%) when compared with all respondents. It is more common to treat bipolar disorder with antipsychotic medications than it is for depression or anxiety, which could account for this difference. With which of the following have you been diagnosed? (Check all that apply.) (Respondents Diagnosed with TD: n=49) substance use disorder 12.24% schizophrenia 6.12% anxiety 55.10% depression 51.02% bipolar disorder 89.80% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% 70.00% 80.00% 90.00% 100.00% MEDICATION 1,695 individuals reported being either currently on a psychiatric medication or had been in the past. 65% had taken or were currently taking anti-depressants, 62% are or were taking mood stabilizers, 52% are or were taking anti-anxiety medications and 48% are or were taking antipsychotic medications. 75% of those taking antipsychotic medications reported that they had been on the medication for longer than 1 year. SIDE EFFECTS Survey participants were asked to indicate which of nine less-commonly reported side effects from psychiatric medications they had experienced and the relative distress each caused in their life. 52% of respondents indicated they had experienced akathisia, defined as a state of agitation, distress and restlessness. In addition to akathisia, nightmares (38%), constipation (37%) and blurred vision (36%) were experienced the most frequently. Have you experienced any of the following less common side effects from psychiatric medication? (n=1695) none of the above constipation nightmares speech interference difficulty swallowing rocking, jerking, flexing, or thrusting of trunk or hips writhing, twisting, dancing movements of fingers or toes uncontrollable movements of the tongue, jaw, or lips akathisia (a state of agitation, distress, and restlessness) blurred vision 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50% Page 2 of 7

When it came to indicating how distressing each side effect experienced was, akathisia remained on top with a weighted average of 3.89, followed again by nightmares at 3.67 on a 5 point scale. Other high distress ranking side effects included uncontrollable movements of the tongue, jaw or lips (3.43/5), speech interference (3.36/5) and difficulty swallowing (3.32/5) Level of Distress of Side Effects on a 5 Point Scale (n=1470) constipation 3.3 nightmares 3.665 speech interference difficulty swallowing *rocking, jerking, flexing, or thrusting of trunk or hips *writhing, twisting, dancing movements of fingers or toes *uncontrollable movements of the tongue, jaw, or lips 3.355 3.32 3.365 3.115 3.43 akathisia (a state of agitation, distress, and restlessness) * side effects common in tardive dyskinesia blurred vision 3.885 3.045 1 1.5 2 2.5 3 3.5 4 4.5 5 (1- not distressed, 5 - extremely distressed). When looking at only individuals who had been diagnosed with Tardive Dyskinesia (TD) (n=49), there was a notably higher ranking of distress caused by side effects commonly associated with TD: rocking, jerking, flexing, or thrusting of trunk or hips (4.67/5), uncontrollable movements of the tongue, jaw or lips (4.23/5) and writhing, twisting, dancing movements of the fingers or toes (3.75/5.) Level of Distress of Side Effects on a 5 Point Scale (Respondents Diagnosed with TD: n=49) constipation nightmares speech interference difficulty swallowing rocking, jerking, flexing, or thrusting of trunk or hips writhing, twisting, dancing movements of fingers or toes uncontrollable movements of the tongue, jaw, or lips akathisia (a state of agitation, distress, and restlessness) blurred vision 3.14 3.88 4.21 3.61 4.67 3.75 4.23 4.17 3.54 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 (1- not distressed, 5 - extremely distressed) Page 3 of 7

TREATMENT STRATEGIES FOR ADDRESSING SIDE EFFECTS Survey participants were asked to share what strategies, if any, they had found helpful in dealing with side effects they were experiencing. Looking at the three most commonly reported side effects (akathisia, nightmares, and constipation), changing the medication dose and adding another medication were most helpful. For those experiencing akathisia, 39.9% reported changing the dose of the medication was the most successful strategy, followed by adding another medication at 26.6%. Those experiencing nightmares seemed to have found the least strategies helpful with nearly 50% indicating none of the listed strategies had been helpful. Changing the medication dose was reported to be helpful for about 24% of the respondents and adding another medication at 17.8%. Those who had experienced constipation indicated that a change in diet (48.7%) was the most effective strategy they had used. For each of these side effects, it is interesting to note, the amount of people indicating that no strategies had been helpful was very high. What strategies have you found to be helpful for each side effect? (n=1438) No strategies 28.76% 26.32% 47.78% Changing the medication dose 11.37% 24.40% 39.85% Spacing out the medication dose 2.17% 7.00% 7.27% Doing relaxation exercises 4.18% 11.95% 19.42% Additional medication added Change in amount or type of physical exercise Change in amount of sleep 3.18% 6.66% 24.25% 17.75% 26.57% 16.22% 15.54% 12.97% 16.42% Change in diet 4.61% 6.02% 48.66% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% constipation nightmares akathisia (a state of agitation, distress, and restlessness) Page 4 of 7

Survey participants were asked about with whom, if anyone, they had talked to about their side effects. 84% of respondents had discussed the side effects with their psychiatrist; 55% had shared with a family member; 42% with a talk therapist; and 41% had discussed their side effects with a primary care physician. Similarly to all respondents, those who had been diagnosed with tardive dyskinesia (TD) also found relief through adding medications (76%) and, to a lesser extent, changing their medication dose (36%). Some had also tried discontinuing the antipsychotic (52%) or changing the brand of medication they were on (48%). What treatments for tardive dyskinesia have you tried? (Check all that apply.) (Respondents Diagnosed with TD: n=49) addition of new medication 76% change in brand of anti-psychotic medication 48% change in dose of anti-psychotic medication 36% discontinuation of anti-psychotic medication 52% 0% 10% 20% 30% 40% 50% 60% 70% 80% 75% of those who have lived with tardive dyskinesia were diagnosed by a psychiatrist. Only 9% had been diagnosed by a neurologist. This is an interesting finding as it is usually common practice to have a diagnosis of tardive dyskinesia confirmed by a neurologist. Individuals living with tardive dyskinesia reported that symptoms of repeated movements of the tongue, jaw, or lips (55%); followed by akathisia (43%) led them to seek professional help. Nearly 60% of participants indicate that they were the first one to notice symptoms. Among our sample of those living with tardive dyskinesia, nearly all (91%) stated that they began experiencing TD side effects while taking an antipsychotic medication. 56% felt that they began experiencing symptoms within the first year they were on the antipsychotic. Survey respondents (n=1544) where they received support dealing with their side effects. 57% reported that their psychiatrists were a support for them followed by family at 35%, psychologists/counselors at 32%, and friends at 25%. Responses indicated minimal use of in-person and online support groups (approximately 8% each) or discussion boards and forums (9%) for support. Notably, nearly 20% of respondents reported that they have no support. This may indicate a need for more education around side effects, as well as a greater focus on how to discuss side effects. Page 5 of 7

Where do/did you get support for dealing with medication side effects? (Check all that apply.) (n=1544) I don t have support other medical professional psychologist/counselor psychiatrist family friends online discussion board or forum online support group in-person support group 9.44% 7.71% 8.38% 19.81% 20.28% 25.33% 31.72% 34.77% 57.11% 0.00% 10.00% 20.00% 30.00% 40.00% 50.00% 60.00% DEMOGRAPHICS Females made up 78% of survey participants, followed by males (20%), trans-gender or other at approximately 1% and another 1% who preferred not to disclose or did not identify with a gender. Females reported experiencing all of the medication side effects more than males. Females also reported being diagnosed with tardive dyskinesia (TD) significantly more than males. 48% of respondents were between the ages of 40-60. Another 40% were younger than 40, and the remaining were older than 60 (11%) or preferred not to disclose (1%). Of note, nearly 60% of those who had been diagnosed with TD were between the ages of 30-50 years old. We expected to see older individuals experiencing TD more frequently. However, our sample size was small (n=49) and the online methods of survey collection may have skewed to a slightly younger demographic. 85% of participants classified themselves as white, 6% as Asian, 2% black or African American, 1% American Native or Alaska Native. Asian American and Native Hawaiian or other Pacific Islander each came in at less than 1% of participants. Nearly 5% chose not to disclose their race. When asked about their employment and/or student status, 46% were employed either full or part time, 11% were students, 12% were retired, and 35% reported that they were currently not employed or a student. 65% shared that they were not receiving disability benefits and 76% had insurance coverage. The demographic breakdown in all categories stayed consistent regardless of the side effect experienced. Page 6 of 7

SUMMARY AND DISCUSSION The results of this survey indicate that side effects from psychiatric medications are a very real problem for many. Of the 1,695 individuals who completed the survey, nearly 90% shared that they had experienced at least one of the less common side effects noted in this survey. All of the side effects were reported as being, at a minimum, distressing (3 on a 5 point scale) indicating that they all are significantly impacting the individuals lives. For people who had experienced akathisia, the distress level neared 4 on a 5 point scale (3.9/5). Individuals with tardive dyskinesia indicated that the distress level from the side effects most commonly associated with TD were even higher (all reported at greater than a 4 on a scale of 1-5.). It was also telling to see that for a large percentage of the side effects, respondents had not found any helpful strategies for dealing with the side effect(s). From this survey, it is unclear whether individuals had tried all of the strategies provided and found them to not be helpful or if they hadn t yet been tried. The results showing that the individual, rather than the clinician, was first to notice side effects of TD (60%); that the symptoms presented within the first year of taking an antipsychotic medication (56%); and that nearly 20% of respondents had found no source of support for dealing with their side effects all point to the need for more education around side effects, as well as a greater focus on how to discuss side effects with clinicians. DBSA hopes to utilize the information gained through this survey to develop resources to: provide a greater understanding of less common medication side effects, including tardive dyskinesia. educate on strategies individuals may wish to try to alleviate these side effects. help individual have more effective discussions about side effects with their health care providers. Page 7 of 7